Castle PE - Search Results

1

Special commentary: patient safety and the next generation of HPV DNA tests.

Kinney W, Stoler MH, Castle PE. Kinney W, et al. Among authors: castle pe. Am J Clin Pathol. 2010 Aug;134(2):193-9. doi: 10.1309/AJCPRI8XPQUEAA3K. Am J Clin Pathol. 2010. PMID: 20660320 Review.

2

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.

Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M. Hildesheim A, et al. Among authors: castle pe. Br J Cancer. 2001 May 4;84(9):1219-26. doi: 10.1054/bjoc.2001.1779. Br J Cancer. 2001. PMID: 11336474 Free PMC article.

3

Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.

Castle PE, Shields T, Kirnbauer R, Manos MM, Burk RD, Glass AG, Scott DR, Sherman ME, Schiffman M. Castle PE, et al. Sex Transm Dis. 2002 Mar;29(3):182-7. doi: 10.1097/00007435-200203000-00009. Sex Transm Dis. 2002. PMID: 11875380

4

Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.

Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, Schussler JE, Schiffman M. Castle PE, et al. J Clin Microbiol. 2002 Mar;40(3):1088-90. doi: 10.1128/JCM.40.3.1088-1090.2002. J Clin Microbiol. 2002. PMID: 11880448 Free PMC article.

5

Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels.

Castle PE, Hildesheim A, Bowman FP, Strickler HD, Walker JL, Pustilnik T, Edwards RP, Crowley-Nowick PA. Castle PE, et al. J Clin Immunol. 2002 Jan;22(1):23-7. doi: 10.1023/a:1014252402630. J Clin Immunol. 2002. PMID: 11958590 Clinical Trial.

6

Comparisons of HPV DNA detection by MY09/11 PCR methods.

Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A, Schussler JE, Burk RD. Castle PE, et al. J Med Virol. 2002 Nov;68(3):417-23. doi: 10.1002/jmv.10220. J Med Virol. 2002. PMID: 12226831

7

A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M. Castle PE, et al. J Natl Cancer Inst. 2002 Sep 18;94(18):1406-14. doi: 10.1093/jnci/94.18.1406. J Natl Cancer Inst. 2002. PMID: 12237286

8

Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.

Schiffman M, Wheeler CM, Castle PE; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Schiffman M, et al. Among authors: castle pe. J Infect Dis. 2002 Oct 15;186(8):1169-72. doi: 10.1086/343816. Epub 2002 Sep 16. J Infect Dis. 2002. PMID: 12355370

9

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.

Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M. Castle PE, et al. Cancer. 2002 Nov 15;95(10):2145-51. doi: 10.1002/cncr.10927. Cancer. 2002. PMID: 12412168 Free article.

10

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.

Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A. Castle PE, et al. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1394-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters